Since an identical BRAF V(600)E is also found in other diverse lymphoid and solid tumours [16, 38], the activated mutant RAF-MEK-ERK module may by analogy also be exploited by tumour cells to selectively by-pass critical microenvironment receptor-ligand dependencies for survival in those neoplasms. The gene discussed is MAP2K7; the disease is neoplasm.